INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 156 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $17,919,244 | +57.7% | 261,633 | +59.3% | 0.03% | +57.9% |
| Q1 2024 | $11,362,709 | +285.7% | 164,201 | +299.2% | 0.02% | +216.7% |
| Q4 2023 | $2,945,659 | -32.8% | 41,129 | -51.1% | 0.01% | -45.5% |
| Q3 2023 | $4,385,665 | +208.4% | 84,194 | +220.6% | 0.01% | +83.3% |
| Q1 2023 | $1,421,979 | +75.6% | 26,260 | +50.8% | 0.01% | +50.0% |
| Q3 2022 | $810,000 | +166.4% | 17,410 | +199.4% | 0.00% | +300.0% |
| Q4 2021 | $304,000 | -9.3% | 5,815 | -29.1% | 0.00% | 0.0% |
| Q2 2021 | $335,000 | -1.8% | 8,198 | -23.6% | 0.00% | -66.7% |
| Q4 2020 | $341,000 | -70.1% | 10,728 | -75.9% | 0.00% | -80.0% |
| Q3 2020 | $1,141,000 | +513.4% | 44,474 | +266.5% | 0.02% | +200.0% |
| Q1 2020 | $186,000 | -83.1% | 12,134 | -91.8% | 0.01% | -50.0% |
| Q3 2019 | $1,100,000 | +58.3% | 147,257 | +175.0% | 0.01% | +42.9% |
| Q2 2019 | $695,000 | +44.2% | 53,545 | +35.3% | 0.01% | +40.0% |
| Q1 2019 | $482,000 | +66.8% | 39,569 | +56.0% | 0.01% | +66.7% |
| Q4 2018 | $289,000 | -45.8% | 25,366 | +3.3% | 0.00% | -50.0% |
| Q3 2018 | $533,000 | -25.5% | 24,567 | -39.3% | 0.01% | -33.3% |
| Q2 2018 | $715,000 | -25.2% | 40,466 | -10.9% | 0.01% | -40.0% |
| Q1 2018 | $956,000 | +267.7% | 45,400 | +175.1% | 0.02% | +200.0% |
| Q3 2017 | $260,000 | -15.0% | 16,505 | -18.6% | 0.01% | -61.5% |
| Q4 2016 | $306,000 | +84.3% | 20,270 | +86.6% | 0.01% | +18.2% |
| Q3 2016 | $166,000 | -56.0% | 10,863 | +55.2% | 0.01% | -73.2% |
| Q4 2015 | $377,000 | – | 7,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCF Advisers, LLC | 375,000 | $15,308,000 | 5.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 113,258 | $4,623,000 | 2.06% |
| Tri Locum Partners LP | 150,783 | $6,155,000 | 2.02% |
| COOPER/HAIMS ADVISORS, LLC | 61,116 | $2,495,000 | 1.64% |
| Vantage Consulting Group Inc | 226,670 | $9,252,000 | 1.61% |
| Nicholas Investment Partners, LP | 598,261 | $24,421,000 | 1.53% |
| Bellevue Group AG | 3,609,919 | $147,357,000 | 1.44% |
| GENERAL AMERICAN INVESTORS CO INC | 350,804 | $14,320,000 | 1.20% |
| Rhenman & Partners Asset Management AB | 429,728 | $17,541,000 | 1.19% |
| WASATCH ADVISORS LP | 6,506,789 | $265,607,000 | 1.08% |